Alemtuzumab therapy for hypereosinophilic syndrome and chronic eosinophilic leukemia.
Verstovsek S, Tefferi A, Kantarjian H, Manshouri T, Luthra R, Pardanani A, Quintás-Cardama A, Ravandi F, Ault P, Bueso-Ramos C, Cortes JE.
Verstovsek S, et al. Among authors: kantarjian h.
Clin Cancer Res. 2009 Jan 1;15(1):368-73. doi: 10.1158/1078-0432.CCR-08-1302.
Clin Cancer Res. 2009.
PMID: 19118067
Free PMC article.